Christopher Malkin
Latest contributions
Why should we consider Bioprosthetic Valve Dysfunction for aortic valve selection?
Performing a high-volume of TAVI implantation, Chris Malkin (UK) shares experience and comments on the new concept of Bioprosthetic Valve Dysfunction with insights from the CoreValve-Evolut 5-year pooled analysis. What does Bioprosthetic Valve Dysfunction (BVD) mean according to the VARC 3 guidelines? What are the clinical...
TAVI challenges: session 4
29 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.
Technical challenges and optimal device choice for complex TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Learn how to anticipate the risks of a valve-in-valve procedure in small surgical prostheses, and discover the latest technological evolutions for treating patients with complex anatomy.
Hot TAVI topics - Cerebral embolic protection
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...
Rapid-fire abstracts: session 3
27 Nov 2022 – From PCR London Valves 2022
Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.
The right valve choice for TAVI patient longevity and durability
18 May 2022 – From EuroPCR 2022
Watch this session to learn about the impact of age and life expectancy on decision-making for TAVI, to become aware of the durability data of the current TAVI platform, and to revise contemporary implantation techniques and procedural goals for future TAVI-in-TAVI.
How should I treat? - TAVI in small anatomy with significant LVOT calcification
20 Jan 2022
An 89-year-old man was referred for treatment of severe symptomatic aortic stenosis. This case describes the decision-making in performing TAVI in a patient with twin challenges of small annulus and significant LVOT calcification.
Author
Author
Author
Treating bicuspid patients, sizing algorithms
18 May 2021 – From EuroPCR 2021
Watch this session presented by Chris Malkin, Sonia Petronio and Amit Segev to learn more about treating bicuspid patients and sizing algorithms.
Experience the Evolut platform in complex cases
23 Nov 2020 – From PCR Valves e-Course
Watch this session if you want to discuss complex TAVI scenarios with your peers and to unravel the technical considerations that are essential to ensure optimal clinical outcomes
